Hawthorne Health, Inc.’s Post

🚨 Join Clinmark’s Round Table Discussion at the Fierce Clinical Summit! 🚨 We’re excited to invite all participants to our upcoming discussion, "STUDY SALVAGE: Understand When It's Time to Fire Your Clinical Partners and What Trial Rescue and Recovery Looks Like," on Thursday, September 26, 2024, from 4:45 PM to 5:30 PM EDT. 🌍 🗣️ What we’ll discuss: We meet to discuss an often-overlooked aspect—while everyone emphasizes collaboration, the reality is often quite different. We believe that creating a discussion around bad experiences is just as important as sharing the good ones, and it’s crucial to show that even in challenging situations, it doesn’t have to be the end of a trial. 🧠 Join us for this important, candid conversation about recognizing when it’s time to part ways with a clinical partner and what trial rescue and recovery can look like. 🤝 Don’t miss it, and stay tuned for more! #ClinicalTrials #StudySalvage #TrialRescue #IndustryInsights #Collaboration #ClinicalResearch #Transparency #TeamClinmark

💚 Why I LOVE Being Part of AK Clinical Research 💚 Strong team? Check ✅ Solid partners? Double-check. ✅✅ Together, we’re like the Avengers of clinical trials, but instead of fighting bad guys, we're battling health challenges. Since we began in 2019, we have embarked on 25 clinical trials, each one pushing us to new heights. Talk about a hive of activity! 🐝- - - - 🌱 🖐 Need a helping hand? 🖐 🔗 Join our journey! Follow AK Clinical Research here on LinkedIn to get updates and insights into the work we do and the difference we make. Still curious about our superpowers? Check out our website to learn more! https://lnkd.in/ddFFQ3EU #ProudTeamMember #ClinicalTrials #HealthcareInnovation #Teamwork #CRO #Biotech #ResearchExcellence

Our 21st BioPharma Clinical Trials Nexus Conference is just around the corner, and it’s a pleasure to introduce our incredible panelists for the session “The Role of Decentralized Clinical Trials and Digitalization: Bridging the Gap in Modern Clinical Research.” This session will bring together some of the brightest minds in the industry to discuss how decentralized clinical trials and digital innovations are reshaping research—making it more accessible, efficient, and patient-focused. 📅 Conference Dates: October 22-23, 2024 📍 Venue: Holiday Inn Piscataway Somerset, New Jersey 📅 Panel Date: Day 2 Meet the panelists: 🎤 Nick Delmonico – CEO and Cofounder, Strados Labs (Moderator) 🎤 Ashlyn Jose, PharmD, MBA, – Director of Clinical Operations, Kyowa Kirin, Inc.- U.S. 🎤 innes meldrum – CEO, AdhereTech 🎤 Prachi Dalal, MS, MBA, CCRP – Senior Clinical Study Manager, Recordati Rare Diseases North America 🎤 Nadia Niemeryanski – Head, Gsap This discussion promises to offer valuable insights on how technology is transforming clinical research. Looking forward to engaging conversations about the future of trials and improving patient outcomes. See you there! 🙌 #ClinicalTrials #DecentralizedTrials #DigitalHealth #BioPharma #PatientCentricity #ClinicalResearch #PharmaInnovation #HealthTech #DigitalTransformation #LifeSciences #FutureOfMedicine #ClinicalOperations

🔬 Exploring the Landscape of Clinical Trials in Australia Thank you, Matthew Britland, John Emmerson, Daniela Caiazza, Nik Zeps, Sophie Mepham PhD and Matt Zeller, for an interesting and comprehensive webinar today. Here are few key takeaways. ▶️ Pros:  🔹 High-Quality Environment: Australia is recognized as a safe, clean, and friendly country.  🔹 High-Quality Execution and Healthcare: Renowned for its leadership in nuclear medicine (e.g. Australian Nuclear Science and Technology Organisation, ANSTO) and great healthcare systems. ▶️ Cons:  🔹 Cost and Accessibility: High expenses and geographical remoteness pose significant challenges.  🔹 Demographic Limitations: A smaller population size complicates the scope of trials, especially for rare diseases. ▶️ Struggles:  🔹 Career Pathways for Research Coordinators: There's a pressing need for defined career progression for research coordinators, paralleling those for doctors and nurses, to aid in retention and motivation.  🔹 Decentralised Trials: Discussed as a solution to encourage broader participation without the need for extensive travel. ▶️ Innovative Aims:  🔹 National One-Stop Shop: A unified approach to streamline processes in clinical trials.  🔹 Panel Wishlist: Fast access to innovations, recognition and career advancement for trial coordinators, and a more harmonized regulatory framework. This webinar highlights the potential and the hurdles in Australia's clinical trials landscape, urging a shift towards integrating research into everyday healthcare. I look forward to seeing how these discussions shape future policies and practices in healthcare research  🙌 #clinicaltrials #healthcareinnovation

Can't wait for this insightful discussion! #clinicaltrialsnexus #clinicaltrials

🌐 Join EmVenio Research for an upcoming webinar on the vital role of efficient study start-up processes in clinical research! The featured speakers will share strategies to streamline the start-up phase—from protocol feasibility to regulatory submissions and site activation. Gain practical insights into overcoming challenges, reducing time-to-initiation, and fostering smooth collaboration between sponsors, CROs, and sites. ➡️ Learn more + register here: https://buff.ly/3ZCRhJA 🌟 Featured speakers: Jack Evans Tara Kidwell #ClinicalTrials #DrugDevelopment #ClinicalResearch #ClinicalOperations #ClinicalData #SiteManagement #ClinicalSites #DecentralizedClinicalTrials #SiteNetwork

GETTING BIOTECHS GLOBALREADY 🌏 GlobalReady is designed to support biotechs from their early pre-clinical through to later phases. All with the one CRO, across the globe, and leveraging the right site relationships and delivering access to patient populations. 🌐 Watch the video 👇 https://lnkd.in/gTtrcAjS Request a Proposal now! https://lnkd.in/gDgtaSqB #AvanceClinical #CRO #GlobalReadybyAvanceClinical #Biotech #ClinicalTrials #DrugDevelopment #PreClinical #EarlyPhase #LatePhase

Türkiye is becoming an attractive destination for clinical trials due to its robust healthcare infrastructure and a large pool of treatment-naive patients. In our latest video interview, CEO of Cromos Pharma, Vlad Bogin, MD, FACP, speaks with Seniz Sagol Tuysuz, the Country Head of Cromos Pharma in Türkiye. They explore why Türkiye is emerging as a biotech hub, discussing the clinical trial landscape, regulatory environment, quality and safety measures, patient recruitment, and best practices for successful trials. Discover why Türkiye should be considered for the next clinical research venture: https://lnkd.in/edcWNWyk #Podcast #Türkiye #CromosPharma 

Türkiye is becoming an attractive destination for clinical trials due to its robust healthcare infrastructure and a large pool of treatment-naive patients. In our latest video interview, CEO of Cromos Pharma, Vlad Bogin, MD, FACP, speaks with Seniz Sagol Tuysuz, the Country Head of Cromos Pharma in Türkiye. They explore why Türkiye is emerging as a biotech hub, discussing the clinical trial landscape, regulatory environment, quality and safety measures, patient recruitment, and best practices for successful trials. Discover why Türkiye should be considered for the next clinical research venture: https://lnkd.in/edcWNWyk #Podcast #Türkiye #CromosPharma

Decision-making in clinical trials can be a real minefield.💣 With so many factors at play, what truly makes sites choose one Sponsor over another? How do you elevate yourself to the title of "Sponsor of Choice"? 🔥 At this year’s DPHARM: Disruptive Innovations to Modernize Clinical Research Idol Disrupt, our CEO, Chris Venezia explored these questions. To become the obvious choice for sites, Sponsors must deliver an experience that stands out from the crowd by simplifying the complex and reducing risk. Read the blog for more details! Link in the comments 👇🏼 #ClinicalTrials #ClinicalResearch #SponsorofChoice #DpharmIdol #IdolDisrupt #Dpharm2024